ETF in Focus: GREK
Health Care: Drugs
SeraCare Life Sciences Inc. (SRLS: NASDAQ)
$3.37 0.07 | 2.12%
02/09/12 - 03:57 PM ET
40.42K / 28.20K
Vol / Avg. Vol:3.31 / 3.30
Open / Prev. Close:3.29 - 3.40
Today's Range:2.58 - 4.51
52 Wk Range:8.20%
Performance YTD:TheStreet Rating:
Portfolios with SRLS
- Portfolio NameUser Type
- Userhiromimini Portfolio 1
Latest SRLS Headlines from TheStreet
- Amag: Hedge Fund Makes Takeover Bid 08.03.11 | 08:08 am
- Stocks Under $5: 2 Names with Insider Buying
09.16.10 | 05:09 am - Stocks Under $5: 2 Names with Insider Buying 09.15.10 | 12:09 pm
- Stocks in Motion: OraSure 12.20.05 | 12:12 pm
- Health Stocks in Motion 12.14.04 | 04:12 pm
- Health Stocks in Motion 07.12.04 | 05:07 pm
Press Releases for SRLS
- SeraCare Expands Infectious Disease Offerings With Six New Product Introductions - PR Newswire 02.09.12 | 08:02 am
- SeraCare Life Sciences To Report First Quarter Fiscal Year 2012 Financial Results On February 10, 2012 - PR Newswire 02.07.12 | 02:02 pm
- SeraCare Life Sciences To Report Fourth Quarter And Fiscal Year 2011 Results On November 17, 2011 - PR Newswire 11.14.11 | 08:11 am
- SeraCare Life Sciences Continues To Expand Product Portfolio - PR Newswire 09.07.11 | 08:09 am
- SeraCare Life Sciences Expands Product Portfolio - PR Newswire 08.18.11 | 09:08 am
- SeraCare Life Sciences Announces Decision To Explore Strategic Alternatives, Including Possible Sale Of The Company - Business Wire 08.01.11 | 07:08 am
- SeraCare Life Sciences Retains Lazard And Announces Company To Report Third Quarter Fiscal Year 2011 Financial Results On July 26, 2011 - PR Newswire 07.18.11 | 08:07 am
- The Law Office Of Abe Shainberg Announces Investigation Of SeraCare Life Sciences, Inc. - Business Wire 06.30.11 | 07:06 pm
- The Law Firm Of Weiss & Lurie Announces Investigation Of SeraCare Life Sciences, Inc. - Business Wire 06.28.11 | 03:06 pm
- The Law Firm Of Levi & Korsinsky, LLP Announces Investigation Of SeraCare Life Sciences, Inc. - Business Wire 06.23.11 | 06:06 pm
Partner Headlines for SRLS
- MSMB Capital Management Proposes Acquisition of SeraCare for $4.25 Per Share - Benzinga 06.23.11 | 09:06 am
- Life Science Portfolios: Reflecting on a Year of Out-Performance - Seeking Alpha 12.29.10 | 05:12 am
- 8 Stocks Bucking the Downtrend - Seeking Alpha 05.09.10 | 03:05 am
